GlassScriptPhysician profile
Giovanni Ramirez Arroyo
NPI 1518402015
$1,185.65
in general payments reported to CMS, 2019-2025
7 companies · $14.32 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $60.00 · 2024: $1,111 · 2025: $14.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,125.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $426.20 | 2024-2025 | Proclaim, Eterna, Ionicrf |
| Saluda Medical Americas, INC. | $188.02 | 2024 | Evoke |
| Si-Bone, INC. | $185.59 | 2024 | |
| Nevro Corp. | $118.55 | 2024 | Senza |
| Spr Therapeutics, INC | $115.33 | 2024 | Sprint Pns System |
| Vertos Medical, INC. | $91.96 | 2024 | Mild Device Kit |
| Grt US Holding, INC. | $60.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giovanni Ramirez Arroyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.